U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C38H44N2O6
Molecular Weight 624.7658
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DAURICINE

SMILES

COC1=C(OC)C=C2[C@@H](CC3=CC=C(OC4=CC(C[C@H]5N(C)CCC6=CC(OC)=C(OC)C=C56)=CC=C4O)C=C3)N(C)CCC2=C1

InChI

InChIKey=AQASRZOCERRGBL-ROJLCIKYSA-N
InChI=1S/C38H44N2O6/c1-39-15-13-26-20-35(42-3)37(44-5)22-29(26)31(39)17-24-7-10-28(11-8-24)46-34-19-25(9-12-33(34)41)18-32-30-23-38(45-6)36(43-4)21-27(30)14-16-40(32)2/h7-12,19-23,31-32,41H,13-18H2,1-6H3/t31-,32-/m1/s1

HIDE SMILES / InChI

Molecular Formula C38H44N2O6
Molecular Weight 624.7658
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Neuroprotective properties of picroside II in a rat model of focal cerebral ischemia.
2010-11-16
Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells.
2010-10
Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines.
2010-07-25
Predictable and linear scale-up of four phenolic alkaloids separation from the roots of Menispermum dauricum using high-performance counter-current chromatography.
2010-07-15
[Studies on the chemical constituents of Callicarpa kochiana].
2010-06
Validated liquid chromatography-tandem mass spectrometry method for quantitative determination of dauricine in human plasma and its application to pharmacokinetic study.
2010-05-01
Pulmonary toxicity and metabolic activation of dauricine in CD-1 mice.
2010-03
Neuroprotective effect of dauricine after transient middle cerebral artery occlusion in rats: involvement of Bcl-2 family proteins.
2010
Inhibitory effects of dauricine on early afterdepolarizations and L-type calcium current.
2009-11
Identification of quinone methide metabolites of dauricine in human liver microsomes and in rat bile.
2009-05
Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells.
2009-05
[Effect of dauricine on apoptosis and expression of apoptogenic protein after transient focal cerebral ischemia-reperfusion injury in rats].
2009-01
Improved RP-HPLC method to determine neferine in dog plasma and its application to pharmacokinetics.
2007-10-01
Genetic and alkaloid analysis of Menispermum dauricum DC. by RAPD and HPLC.
2007-07-13
Identification of dauricine and its metabolites in rat urine by liquid chromatography-tandem mass spectrometry.
2007-07-01
Neuroprotective effect of dauricine in cortical neuron culture exposed to hypoxia and hypoglycemia: involvement of correcting perturbed calcium homeostasis.
2007-06
Neuroprotective effects of dauricine against apoptosis induced by transient focal cerebral ischaemia in rats via a mitochondrial pathway.
2007-03
Inhibitory effect of dauricine on inflammatory process following focal cerebral ischemia/reperfusion in rats.
2007
[Study on the chemical constituents of Mitragyna rotundifolia].
2006-06
[Effect of phenolic alkaloids of Menispermum dauricum on thrombosis and platelet aggregation].
2005-10
Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell.
2004-12
[Protective effects of phenolic alkaloids from Menispermum dauricum on inflammatory injury following focal cerebral ischemia-reperfusion in rats].
2004-08
Pharmacokinetic-pharmacodynamic modeling of daurisoline and dauricine in beagle dogs.
2003-10
Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives.
2002-12
Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells.
2002-07
Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
2002-05
Dauricine-induced changes in monophasic action potentials and effective refractory period of rabbit left ventricle in situ.
2002-04
[Poteintation of vincristine-induced apoptosis by tetrandrine, neferine and dauricine in the human mammary MCF-7 multidrug-resistant cells].
2001-02
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:54:17 GMT 2025
Edited
by admin
on Mon Mar 31 19:54:17 GMT 2025
Record UNII
8QTO90G5W5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-36413
Preferred Name English
DAURICINE
MI  
Common Name English
DAURICINE [MI]
Common Name English
4-(((1R)-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-1-ISOQUINOLINYL)METHYL)-2-(4-(((1R)-1,2,3,4-TETRAHYDRO-6,7-DIMETHOXY-2-METHYL-1-ISOQUINOLINYL)METHYL)PHENOXY)PHENOL
Systematic Name English
Code System Code Type Description
WIKIPEDIA
Dauricine
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
MESH
C035934
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
EPA CompTox
DTXSID90966808
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
CAS
524-17-4
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
MERCK INDEX
m4105
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY Merck Index
CHEBI
4331
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
PUBCHEM
73400
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
NSC
36413
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY
FDA UNII
8QTO90G5W5
Created by admin on Mon Mar 31 19:54:17 GMT 2025 , Edited by admin on Mon Mar 31 19:54:17 GMT 2025
PRIMARY